PRISM MEDICO AND PHARMACY LTD.

PRISM MEDICO AND PHARMACY LTD's Board of Directors, at their meeting on May 28, 2026, approved the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026. The company also confirmed that the Independent Auditor's Report for the financial year ended March 31, 2026, issued by C.A. Garg Mendiratta & Associates, contains an unmodified opinion. The audit was conducted in accordance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Prism Medico and Pharmacy Ltd has scheduled a Board of Directors meeting on May 28, 2026, to consider and approve the audited standalone financial results for the quarter and financial year ended March 31, 2026. The meeting will also address other routine business matters of the company.

Prism Medico and Pharmacy Ltd has appointed M/s. S Harpreet and Associates, Chartered Accountants, as their internal auditors for the financial year 2025-2026. The decision was made during a Board of Directors meeting held on May 11, 2026, which commenced at 04:00 P.M. and concluded at 04:30 P.M.

Prism Medico and Pharmacy Ltd's board approved the allotment of 75,00,000 equity shares and 50,00,000 convertible warrants on a preferential basis, each at an issue price of ₹10. This decision follows the special resolution passed in the Extra-ordinary General Meeting held on March 20, 2026, and the in-principle approval from BSE Ltd on March 25, 2026. The board meeting commenced at 11:00 am and concluded at 4:00 pm.

Prism Medico and Pharmacy Ltd's board approved the allotment of 75,00,000 equity shares and 50,00,000 convertible warrants on a preferential basis, each at an issue price of ₹10. This decision follows the special resolution passed on March 20, 2026, and BSE's in-principle approval on March 25, 2026. The board meeting, held on May 05, 2026, commenced at 11:00 am and concluded at 4:00 pm.

Prism Medico and Pharmacy Ltd. has announced that the promoters of the company have confirmed that none of them have encumbered the shares held by them during the financial year ended 31st March, 2026. This disclosure was made in accordance with Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. A copy of the confirmation given by one of the promoters on behalf of others promoter and persons acting in concert is enclosed for record.

Prism Medico and Pharmacy Ltd has announced that it will not be issuing any non-convertible securities for which interest, dividend, or principal amount will be payable during the quarter beginning from 1st April, 2026 and ending on 30th June, 2026. This information was shared in accordance with Regulation 57(4) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR).

Prism Medico and Pharmacy Ltd clarified a significant movement in their security price at the stock exchange, stating that all material information has been disclosed in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company highlights that the price movement is due to market conditions and speculation, over which they have no control. The promoter and KMPs have not dealt with any securities in the recent past. The company reiterates its commitment to informing stock exchanges about any price-sensitive information as required.

Prism Medico and Pharmacy Ltd. held an Extraordinary General Meeting on 20th March 2026 through Video Conferencing/Other Audio Visual Means. The meeting, chaired by Mrs. Sakshi Laller, transacted two special resolutions: altering Clause 15 of the Articles of Association and issuing equity shares and convertible warrants on preferential basis. There were no queries raised by any shareholder during the meeting. The voting results will be communicated to the exchanges after receiving the Scrutinizer's Report on remote e-voting held prior to EGM and e-voting held during the EGM.

Prism Medico and Pharmacy Ltd has announced an Extra Ordinary General Meeting (EGM) to be held on March 20, 2026, at 1:00 PM through Video Conferencing (VC) or Other Audio Visual Means (OAVM™). The company's Register of Members and Share Transfer Books will be closed from March 14 to March 20, 2026, for the purpose of the EGM. The EGM cut-off date for E-Voting is Friday, March 13, 2026, with remote E-Voting commencing on Tuesday, March 17, 2026, and ending on Thursday, March 19, 2026.